Reaction
Blood Thyroid Stimulating Hormone Abnormal reporting signals
As of the last recalculation, Blood Thyroid Stimulating Hormone Abnormal appears in 1,816 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is LEVOTHYROXINE SODIUM (PRR 54.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Levothyroxine Sodium | 825 | 54.3 | 54.4 |
| Thyroid, Porcine | 43 | 47.4 | 47.5 |
| Liothyronine Sodium | 35 | 46.9 | 47.1 |
| Alemtuzumab | 43 | 26.1 | 26.1 |
| Levothyroxine Sodium Anhydrous | 114 | 13.8 | 13.9 |
| Pembrolizumab | 73 | 8.2 | 8.2 |
| Ribociclib | 20 | 7.3 | 7.3 |
| Cabozantinib | 25 | 6.0 | 6.0 |
| Nivolumab | 41 | 5.0 | 5.0 |
| Peginterferon Alfa-2A | 23 | 4.9 | 4.9 |
| Lenvatinib | 14 | 4.9 | 4.9 |
| Asfotase Alfa | 4 | 4.6 | 4.6 |
| Axitinib | 7 | 4.1 | 4.1 |
| Brivaracetam | 3 | 3.8 | 3.8 |